ClinicalTrials.gg
CompletedNCT07951710Updated Nov 20, 2026

Serratus Anterior Plane Block at the Third Rib Level After Breast Cancer Surgery With Axillary Intervention

An interventional study of Serratus anterior plane block and Fentanyl (IV) in Breast Neoplasms and Pain, Postoperative, sponsored by Sanliurfa Education and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Sanliurfa Education and Research Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 years 1 month after the study started (first participant enrolled Sep 2023, registered Nov 2026).
Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 400 studies in Breast Neoplasms with a site in Turkey — 83 open to participants now, 129 under way, 46 of them phase 3. Breast Neoplasms · Turkey.

Enrollment
179th of 321
84 · median 100
Started
2023
with 45 others
No phase
184 of 400
48 open now
Registered
400th of 400
by date

Among the 400 studies in Breast Neoplasms with a site in Turkey, this one is the 179th largest by enrollment of the 321 interventional ones that give a count, is one of 46 that started in 2023, is one of 184 with no phase, and was the 400th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,322 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

83 of the 400 studies in Breast Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

78 more — sign in →

All 83 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,575 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 400 studies in Breast Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

This randomized, open-label trial compared an ultrasound-guided serratus anterior plane (SAP) block performed at the third rib level at the end of surgery plus fentanyl patient-controlled analgesia (PCA) with PCA alone in women undergoing breast cancer surgery with an axillary procedure. The primary outcome was cumulative PCA fentanyl consumption in the first 12 postoperative hours.

Read the detailed description

Women aged 18 to 65 years with ASA physical status I-III who were scheduled for elective unilateral breast cancer surgery with sentinel lymph node biopsy or axillary lymph node dissection were randomized by the sealed-envelope method to two groups. All patients received standardized general anesthesia. In Group S, an ultrasound-guided SAP block was performed after completion of surgery and before emergence, at the level where the third rib crosses the midaxillary line, with 30 mL of 0.25% bupivacaine injected into the fascial plane deep to the serratus anterior muscle. Group H received no block. Both groups received intravenous fentanyl PCA for 24 hours (20 µg bolus, 15-minute lockout, no basal infusion). No sham block was performed, and the study was open-label. Fentanyl consumption, PCA demands, and pain scores were recorded at 0, 2, 6, 12, and 24 hours after surgery. Time to first mobilization, pain during arm abduction at 24 hours, and postoperative nausea and vomiting were also recorded. This study was registered retrospectively, after completion of enrollment.

03

Conditions studied

  • Breast Neoplasms
  • Pain, Postoperative

Keywords

  • serratus anterior plane block
  • Third Rib Level
  • Axillary Dissection
  • Breast Cancer Surgery
  • Fentanyl
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elective unilateral breast cancer surgery with sentinel lymph node or axillary lymph node dissection I-III Written

Exclusion criteria

Exclusion Criteria:

  • IV-V Emergency surgery Pregnancy Allergy to local anesthetics Severe cardiovascular or cerebrovascular disease Coagulation disorder Infection at the block site or systemic infection Refusal of the regional technique Intellectual disability or inability to cooperate Severe hepatic or renal dysfunction Planned bilateral surgery
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Group S

    Ultrasound-guided serratus anterior plane block at the third rib level after surgery, plus intravenous fentanyl patient-controlled analgesia for 24 hours.

    Procedure: Serratus anterior plane block · Drug: Fentanyl (IV)

  • Active comparator
    Group H

    Intravenous fentanyl patient-controlled analgesia for 24 hours, without a block.

    Drug: Fentanyl (IV)

Interventions

  • ProcedureSerratus anterior plane block

    Ultrasound-guided block at the third rib level on the midaxillary line with 30 mL of 0.25% bupivacaine, performed after surgery and before emergence from general anesthesia.

  • DrugFentanylStudies of FentanylFentanyl pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Intravenous fentanyl 10 µg/mL by patient-controlled analgesia pump for 24 hours; 20 µg bolus, 15-minute lockout, no basal infusion.

06

What researchers measure

Primary outcomes

  1. Cumulative fentanyl consumption at 12 hours

    Total fentanyl delivered by the PCA pump (µg)

    Time frame: First 12 hours after surgery

Secondary outcomes

  1. Cumulative fentanyl consumption at other time points

    otal fentanyl delivered by the PCA pump (µg)

    Time frame: 0, 2, 6, and 24 hours after surgery

  2. Postoperative pain score

    Numeric Rating Scale, 0 (no pain) to 10 (worst pain); higher scores indicate worse pain

    Time frame: 0, 2, 6, 12, and 24 hours after surgery

  3. Number of PCA demands

    Cumulative number of PCA button presses

    Time frame: 12 and 24 hours after surgery

  4. Time to first mobilization

    Hours until the patient gets out of bed and walks 5 to 10 meters

    Time frame: Up to 24 hours after surgery

  5. Pain score during arm abduction

    Numeric Rating Scale (0 to 10) during approximately 45° abduction of the ipsilateral arm; higher scores indicate worse pain

    Time frame: 24 hours after surgery

  6. Postoperative nausea and vomiting

    Number of patients with nausea and/or vomiting

    Time frame: Up to 24 hours after surgery

07

Study locations

1 site
  • Gaziantep University Faculty of Medicine, Department of Anesthesiology and Reanimation
    Gaziantep, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2023 to primary completion in Feb 2024, 4 months.

Of 2,669 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's 4 months is below that.

Counting every sponsor, half of 2,779 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 20, 2026
StartActual
Sep 23, 2023
Primary completionActual
Feb 15, 2024
CompletionActual
Feb 16, 2024
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07951710
Lead sponsor
Sanliurfa Education and Research Hospital
Responsible party
Abdurrahman Çiçekli (Specialist physician, department of anestesiology and reanimation, Sanliurfa Education and Research Hospital) — Principal investigator
First posted
Nov 20, 2026
Start date
Sep 23, 2023
Primary completion
Feb 15, 2024
Completion
Feb 16, 2024
Last update
Nov 20, 2026

Study contacts

Abdurrahman Çiçekli, MD Gaziantep University Faculty of Medicine, Department of Anesth
principal investigator · University of Gaziantep

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion